Hee Kwan Yoon

Learn More
PURPOSE Intrahepatic cholangiocarcinoma (ICC), a highly malignant hepatobiliary cancer, has a poor prognosis and is refractory to conventional therapies. The aim of this study is to discover a novel molecular target for the treatment of ICC. EXPERIMENTAL DESIGN To discover novel cancer-associated membrane antigens expressed in ICC cells, we generated(More)
  • 1